nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—hypertension—type 2 diabetes mellitus	0.31	1	CtDrD
Verapamil—KCNJ11—type 2 diabetes mellitus	0.092	0.467	CbGaD
Verapamil—ABCC2—type 2 diabetes mellitus	0.0497	0.253	CbGaD
Verapamil—CYP1A2—type 2 diabetes mellitus	0.0332	0.169	CbGaD
Verapamil—KCNJ11—Tolazamide—type 2 diabetes mellitus	0.0256	0.0764	CbGbCtD
Verapamil—KCNJ11—Glimepiride—type 2 diabetes mellitus	0.0228	0.0681	CbGbCtD
Verapamil—CYP3A4—type 2 diabetes mellitus	0.022	0.112	CbGaD
Verapamil—KCNJ11—Glipizide—type 2 diabetes mellitus	0.0208	0.0623	CbGbCtD
Verapamil—KCNJ11—Gliclazide—type 2 diabetes mellitus	0.0194	0.0579	CbGbCtD
Verapamil—KCNJ11—Repaglinide—type 2 diabetes mellitus	0.0182	0.0545	CbGbCtD
Verapamil—KCNJ11—Chlorpropamide—type 2 diabetes mellitus	0.0165	0.0493	CbGbCtD
Verapamil—KCNJ11—Tolbutamide—type 2 diabetes mellitus	0.0147	0.0439	CbGbCtD
Verapamil—KCNJ11—Nateglinide—type 2 diabetes mellitus	0.0125	0.0373	CbGbCtD
Verapamil—CYP2C18—Tolbutamide—type 2 diabetes mellitus	0.0103	0.0308	CbGbCtD
Verapamil—KCNJ11—Glyburide—type 2 diabetes mellitus	0.00843	0.0252	CbGbCtD
Verapamil—ABCC4—Nateglinide—type 2 diabetes mellitus	0.00733	0.0219	CbGbCtD
Verapamil—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.00724	0.0217	CbGbCtD
Verapamil—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.00655	0.0196	CbGbCtD
Verapamil—ABCC3—Glyburide—type 2 diabetes mellitus	0.00648	0.0194	CbGbCtD
Verapamil—SLCO1A2—Tolbutamide—type 2 diabetes mellitus	0.00619	0.0185	CbGbCtD
Verapamil—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.00604	0.0181	CbGbCtD
Verapamil—ABCB11—Glyburide—type 2 diabetes mellitus	0.0056	0.0168	CbGbCtD
Verapamil—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.00534	0.016	CbGbCtD
Verapamil—CACNA1S—pes—type 2 diabetes mellitus	0.00417	0.199	CbGeAlD
Verapamil—ABCC1—Glyburide—type 2 diabetes mellitus	0.00398	0.0119	CbGbCtD
Verapamil—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.00383	0.0115	CbGbCtD
Verapamil—SLCO1A2—Glyburide—type 2 diabetes mellitus	0.00355	0.0106	CbGbCtD
Verapamil—SLCO1B1—Losartan—type 2 diabetes mellitus	0.00307	0.00917	CbGbCtD
Verapamil—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.00306	0.00917	CbGbCtD
Verapamil—ABCC2—Glyburide—type 2 diabetes mellitus	0.00295	0.00881	CbGbCtD
Verapamil—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.00291	0.00871	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.00291	0.00871	CbGbCtD
Verapamil—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00291	0.00871	CbGbCtD
Verapamil—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.00277	0.00829	CbGbCtD
Verapamil—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00273	0.00818	CbGbCtD
Verapamil—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00267	0.008	CbGbCtD
Verapamil—ABCG2—Glyburide—type 2 diabetes mellitus	0.00266	0.00797	CbGbCtD
Verapamil—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00259	0.00776	CbGbCtD
Verapamil—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.00256	0.00765	CbGbCtD
Verapamil—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.00247	0.00739	CbGbCtD
Verapamil—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00245	0.00731	CbGbCtD
Verapamil—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00233	0.00695	CbGbCtD
Verapamil—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00233	0.00695	CbGbCtD
Verapamil—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00227	0.0068	CbGbCtD
Verapamil—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.00218	0.00653	CbGbCtD
Verapamil—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00215	0.00642	CbGbCtD
Verapamil—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00207	0.0062	CbGbCtD
Verapamil—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00201	0.00602	CbGbCtD
Verapamil—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00198	0.00592	CbGbCtD
Verapamil—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00193	0.00578	CbGbCtD
Verapamil—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00193	0.00578	CbGbCtD
Verapamil—SLC22A1—Metformin—type 2 diabetes mellitus	0.0019	0.00568	CbGbCtD
Verapamil—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00188	0.00561	CbGbCtD
Verapamil—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00178	0.00534	CbGbCtD
Verapamil—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00177	0.00529	CbGbCtD
Verapamil—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00174	0.00522	CbGbCtD
Verapamil—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00172	0.00515	CbGbCtD
Verapamil—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00163	0.00488	CbGbCtD
Verapamil—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00158	0.00471	CbGbCtD
Verapamil—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00156	0.00466	CbGbCtD
Verapamil—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00155	0.00465	CbGbCtD
Verapamil—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00147	0.00441	CbGbCtD
Verapamil—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00147	0.00438	CbGbCtD
Verapamil—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00142	0.00425	CbGbCtD
Verapamil—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0014	0.0042	CbGbCtD
Verapamil—CYP3A5—Losartan—type 2 diabetes mellitus	0.00135	0.00404	CbGbCtD
Verapamil—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00134	0.00401	CbGbCtD
Verapamil—CYP2C8—Losartan—type 2 diabetes mellitus	0.0013	0.00388	CbGbCtD
Verapamil—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00129	0.00385	CbGbCtD
Verapamil—CACNA1A—nerve—type 2 diabetes mellitus	0.00129	0.0613	CbGeAlD
Verapamil—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00128	0.00384	CbGbCtD
Verapamil—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00124	0.00372	CbGbCtD
Verapamil—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00119	0.00356	CbGbCtD
Verapamil—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00112	0.00336	CbGbCtD
Verapamil—CYP2C19—Losartan—type 2 diabetes mellitus	0.00109	0.00326	CbGbCtD
Verapamil—CYP1A2—Losartan—type 2 diabetes mellitus	0.001	0.003	CbGbCtD
Verapamil—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00099	0.00296	CbGbCtD
Verapamil—ABCB1—Glyburide—type 2 diabetes mellitus	0.00096	0.00287	CbGbCtD
Verapamil—CYP2C9—Losartan—type 2 diabetes mellitus	0.000905	0.00271	CbGbCtD
Verapamil—ABCB1—Losartan—type 2 diabetes mellitus	0.000878	0.00263	CbGbCtD
Verapamil—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.000852	0.00255	CbGbCtD
Verapamil—CACNA1F—retina—type 2 diabetes mellitus	0.000848	0.0404	CbGeAlD
Verapamil—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.000817	0.00244	CbGbCtD
Verapamil—CYP3A4—Orlistat—type 2 diabetes mellitus	0.000817	0.00244	CbGbCtD
Verapamil—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.000772	0.00231	CbGbCtD
Verapamil—CACNA1A—islet of Langerhans—type 2 diabetes mellitus	0.000623	0.0297	CbGeAlD
Verapamil—CYP3A4—Glyburide—type 2 diabetes mellitus	0.000575	0.00172	CbGbCtD
Verapamil—CYP3A4—Losartan—type 2 diabetes mellitus	0.000526	0.00157	CbGbCtD
Verapamil—CACNA1S—cardiovascular system—type 2 diabetes mellitus	0.000404	0.0193	CbGeAlD
Verapamil—CACNB1—cardiovascular system—type 2 diabetes mellitus	0.000377	0.018	CbGeAlD
Verapamil—CACNB2—islet of Langerhans—type 2 diabetes mellitus	0.000336	0.016	CbGeAlD
Verapamil—CACNB1—adipose tissue—type 2 diabetes mellitus	0.000332	0.0158	CbGeAlD
Verapamil—CACNB3—adipose tissue—type 2 diabetes mellitus	0.000319	0.0152	CbGeAlD
Verapamil—KCNJ11—islet of Langerhans—type 2 diabetes mellitus	0.000319	0.0152	CbGeAlD
Verapamil—CACNA1D—islet of Langerhans—type 2 diabetes mellitus	0.000294	0.014	CbGeAlD
Verapamil—CACNB2—retina—type 2 diabetes mellitus	0.000287	0.0137	CbGeAlD
Verapamil—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000259	0.0124	CbGeAlD
Verapamil—CACNA1H—cardiovascular system—type 2 diabetes mellitus	0.000257	0.0123	CbGeAlD
Verapamil—CACNB2—cardiovascular system—type 2 diabetes mellitus	0.000243	0.0116	CbGeAlD
Verapamil—CACNB2—cortex of kidney—type 2 diabetes mellitus	0.000231	0.011	CbGeAlD
Verapamil—KCNJ11—cardiovascular system—type 2 diabetes mellitus	0.000231	0.011	CbGeAlD
Verapamil—KCNJ11—pancreas—type 2 diabetes mellitus	0.000224	0.0107	CbGeAlD
Verapamil—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000222	0.0106	CbGeAlD
Verapamil—CACNA1D—cardiovascular system—type 2 diabetes mellitus	0.000212	0.0101	CbGeAlD
Verapamil—CACNA1D—pancreas—type 2 diabetes mellitus	0.000206	0.00983	CbGeAlD
Verapamil—CACNA1C—cardiovascular system—type 2 diabetes mellitus	0.000196	0.00934	CbGeAlD
Verapamil—SCN5A—cardiovascular system—type 2 diabetes mellitus	0.00019	0.00905	CbGeAlD
Verapamil—SLC22A4—nephron tubule—type 2 diabetes mellitus	0.000186	0.00885	CbGeAlD
Verapamil—SLCO1B1—kidney—type 2 diabetes mellitus	0.000184	0.00876	CbGeAlD
Verapamil—CYP2C18—liver—type 2 diabetes mellitus	0.000178	0.00849	CbGeAlD
Verapamil—ABCC3—kidney—type 2 diabetes mellitus	0.000174	0.00831	CbGeAlD
Verapamil—ABCC10—kidney—type 2 diabetes mellitus	0.000174	0.00827	CbGeAlD
Verapamil—ABCB11—liver—type 2 diabetes mellitus	0.000173	0.00826	CbGeAlD
Verapamil—CACNA1C—adipose tissue—type 2 diabetes mellitus	0.000173	0.00823	CbGeAlD
Verapamil—CYP3A7—liver—type 2 diabetes mellitus	0.000169	0.00807	CbGeAlD
Verapamil—ABCC10—cortex of kidney—type 2 diabetes mellitus	0.000169	0.00806	CbGeAlD
Verapamil—ABCC4—nephron tubule—type 2 diabetes mellitus	0.000164	0.00781	CbGeAlD
Verapamil—SLC22A4—kidney—type 2 diabetes mellitus	0.000163	0.00777	CbGeAlD
Verapamil—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.000161	0.00769	CbGeAlD
Verapamil—CACNA1H—liver—type 2 diabetes mellitus	0.000159	0.00758	CbGeAlD
Verapamil—SLC22A4—cortex of kidney—type 2 diabetes mellitus	0.000159	0.00757	CbGeAlD
Verapamil—ABCC2—nephron tubule—type 2 diabetes mellitus	0.000159	0.00756	CbGeAlD
Verapamil—ABCC3—adipose tissue—type 2 diabetes mellitus	0.000157	0.00749	CbGeAlD
Verapamil—ABCC10—adipose tissue—type 2 diabetes mellitus	0.000156	0.00745	CbGeAlD
Verapamil—SLC22A1—kidney—type 2 diabetes mellitus	0.000155	0.0074	CbGeAlD
Verapamil—CACNB2—liver—type 2 diabetes mellitus	0.00015	0.00716	CbGeAlD
Verapamil—SLCO1A2—kidney—type 2 diabetes mellitus	0.00015	0.00713	CbGeAlD
Verapamil—SLC22A4—adipose tissue—type 2 diabetes mellitus	0.000147	0.00701	CbGeAlD
Verapamil—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000144	0.00686	CbGeAlD
Verapamil—ABCC4—kidney—type 2 diabetes mellitus	0.000144	0.00686	CbGeAlD
Verapamil—ABCC4—pancreas—type 2 diabetes mellitus	0.000143	0.00682	CbGeAlD
Verapamil—ABCC4—cortex of kidney—type 2 diabetes mellitus	0.00014	0.00668	CbGeAlD
Verapamil—SLC22A1—adipose tissue—type 2 diabetes mellitus	0.00014	0.00667	CbGeAlD
Verapamil—ABCC2—kidney—type 2 diabetes mellitus	0.000139	0.00664	CbGeAlD
Verapamil—ABCC2—cortex of kidney—type 2 diabetes mellitus	0.000136	0.00647	CbGeAlD
Verapamil—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000133	0.00635	CbGeAlD
Verapamil—CACNA1D—liver—type 2 diabetes mellitus	0.000131	0.00626	CbGeAlD
Verapamil—SLC22A5—retina—type 2 diabetes mellitus	0.00013	0.00622	CbGeAlD
Verapamil—ABCC4—adipose tissue—type 2 diabetes mellitus	0.00013	0.00618	CbGeAlD
Verapamil—SLC22A5—nephron tubule—type 2 diabetes mellitus	0.000123	0.00585	CbGeAlD
Verapamil—ABCC1—cortex of kidney—type 2 diabetes mellitus	0.00012	0.0057	CbGeAlD
Verapamil—KCNH2—cardiovascular system—type 2 diabetes mellitus	0.000117	0.00556	CbGeAlD
Verapamil—SLCO1B1—liver—type 2 diabetes mellitus	0.000116	0.00554	CbGeAlD
Verapamil—ABCG2—nephron tubule—type 2 diabetes mellitus	0.000116	0.00551	CbGeAlD
Verapamil—ABCC1—adipose tissue—type 2 diabetes mellitus	0.000111	0.00527	CbGeAlD
Verapamil—ABCC3—liver—type 2 diabetes mellitus	0.00011	0.00525	CbGeAlD
Verapamil—ABCC10—liver—type 2 diabetes mellitus	0.00011	0.00523	CbGeAlD
Verapamil—SLC22A5—kidney—type 2 diabetes mellitus	0.000108	0.00514	CbGeAlD
Verapamil—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000107	0.00512	CbGeAlD
Verapamil—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000107	0.00508	CbGeAlD
Verapamil—SLC22A5—cortex of kidney—type 2 diabetes mellitus	0.000105	0.00501	CbGeAlD
Verapamil—CYP2C8—kidney—type 2 diabetes mellitus	0.000105	0.00498	CbGeAlD
Verapamil—SLC22A1—liver—type 2 diabetes mellitus	9.82e-05	0.00468	CbGeAlD
Verapamil—SLC22A5—adipose tissue—type 2 diabetes mellitus	9.73e-05	0.00464	CbGeAlD
Verapamil—CYP2B6—cardiovascular system—type 2 diabetes mellitus	9.58e-05	0.00457	CbGeAlD
Verapamil—CYP2C9—cardiovascular system—type 2 diabetes mellitus	9.49e-05	0.00452	CbGeAlD
Verapamil—SLCO1A2—liver—type 2 diabetes mellitus	9.46e-05	0.00451	CbGeAlD
Verapamil—CYP3A5—kidney—type 2 diabetes mellitus	9.44e-05	0.0045	CbGeAlD
Verapamil—CYP2B6—kidney—type 2 diabetes mellitus	9.38e-05	0.00447	CbGeAlD
Verapamil—CYP3A5—pancreas—type 2 diabetes mellitus	9.37e-05	0.00447	CbGeAlD
Verapamil—CYP3A5—cortex of kidney—type 2 diabetes mellitus	9.19e-05	0.00438	CbGeAlD
Verapamil—ABCG2—adipose tissue—type 2 diabetes mellitus	9.16e-05	0.00436	CbGeAlD
Verapamil—ABCC4—liver—type 2 diabetes mellitus	9.1e-05	0.00434	CbGeAlD
Verapamil—ABCC2—liver—type 2 diabetes mellitus	8.81e-05	0.0042	CbGeAlD
Verapamil—CYP3A5—adipose tissue—type 2 diabetes mellitus	8.5e-05	0.00405	CbGeAlD
Verapamil—ABCC1—liver—type 2 diabetes mellitus	7.76e-05	0.0037	CbGeAlD
Verapamil—CYP2C19—liver—type 2 diabetes mellitus	7.57e-05	0.00361	CbGeAlD
Verapamil—ABCB1—islet of Langerhans—type 2 diabetes mellitus	7.08e-05	0.00337	CbGeAlD
Verapamil—CYP3A4—kidney—type 2 diabetes mellitus	7.08e-05	0.00337	CbGeAlD
Verapamil—CYP2D6—kidney—type 2 diabetes mellitus	6.97e-05	0.00332	CbGeAlD
Verapamil—SLC22A5—liver—type 2 diabetes mellitus	6.83e-05	0.00325	CbGeAlD
Verapamil—CYP2C8—liver—type 2 diabetes mellitus	6.61e-05	0.00315	CbGeAlD
Verapamil—ABCG2—liver—type 2 diabetes mellitus	6.42e-05	0.00306	CbGeAlD
Verapamil—CYP1A2—liver—type 2 diabetes mellitus	6.18e-05	0.00295	CbGeAlD
Verapamil—ABCB1—retina—type 2 diabetes mellitus	6.06e-05	0.00289	CbGeAlD
Verapamil—CYP3A5—liver—type 2 diabetes mellitus	5.96e-05	0.00284	CbGeAlD
Verapamil—CYP2B6—liver—type 2 diabetes mellitus	5.93e-05	0.00282	CbGeAlD
Verapamil—CYP2C9—liver—type 2 diabetes mellitus	5.87e-05	0.0028	CbGeAlD
Verapamil—ABCB1—nephron tubule—type 2 diabetes mellitus	5.7e-05	0.00272	CbGeAlD
Verapamil—Insomnia—Gliclazide—type 2 diabetes mellitus	5.27e-05	0.000706	CcSEcCtD
Verapamil—Shock—Valsartan—type 2 diabetes mellitus	5.26e-05	0.000705	CcSEcCtD
Verapamil—Infection—Orlistat—type 2 diabetes mellitus	5.25e-05	0.000704	CcSEcCtD
Verapamil—Loss of consciousness—Metformin—type 2 diabetes mellitus	5.25e-05	0.000703	CcSEcCtD
Verapamil—Paraesthesia—Gliclazide—type 2 diabetes mellitus	5.23e-05	0.000701	CcSEcCtD
Verapamil—Hepatitis—Ramipril—type 2 diabetes mellitus	5.22e-05	0.0007	CcSEcCtD
Verapamil—Dizziness—Glimepiride—type 2 diabetes mellitus	5.2e-05	0.000697	CcSEcCtD
Verapamil—Dyspnoea—Gliclazide—type 2 diabetes mellitus	5.19e-05	0.000696	CcSEcCtD
Verapamil—Dizziness—Sitagliptin—type 2 diabetes mellitus	5.18e-05	0.000695	CcSEcCtD
Verapamil—Agitation—Irbesartan—type 2 diabetes mellitus	5.18e-05	0.000694	CcSEcCtD
Verapamil—Somnolence—Gliclazide—type 2 diabetes mellitus	5.18e-05	0.000694	CcSEcCtD
Verapamil—Hypertension—Metformin—type 2 diabetes mellitus	5.15e-05	0.000691	CcSEcCtD
Verapamil—Urticaria—Glyburide—type 2 diabetes mellitus	5.15e-05	0.00069	CcSEcCtD
Verapamil—Angioedema—Irbesartan—type 2 diabetes mellitus	5.15e-05	0.00069	CcSEcCtD
Verapamil—Oedema peripheral—Ramipril—type 2 diabetes mellitus	5.14e-05	0.000689	CcSEcCtD
Verapamil—Dyspepsia—Gliclazide—type 2 diabetes mellitus	5.13e-05	0.000687	CcSEcCtD
Verapamil—ABCB1—cardiovascular system—type 2 diabetes mellitus	5.12e-05	0.00244	CbGeAlD
Verapamil—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	5.11e-05	0.000685	CcSEcCtD
Verapamil—Muscle spasms—Losartan—type 2 diabetes mellitus	5.1e-05	0.000683	CcSEcCtD
Verapamil—Asthenia—Bromocriptine—type 2 diabetes mellitus	5.09e-05	0.000682	CcSEcCtD
Verapamil—Chest pain—Metformin—type 2 diabetes mellitus	5.08e-05	0.000681	CcSEcCtD
Verapamil—Myalgia—Metformin—type 2 diabetes mellitus	5.08e-05	0.000681	CcSEcCtD
Verapamil—Vertigo—Irbesartan—type 2 diabetes mellitus	5.06e-05	0.000678	CcSEcCtD
Verapamil—Headache—Pioglitazone—type 2 diabetes mellitus	5.06e-05	0.000678	CcSEcCtD
Verapamil—Syncope—Irbesartan—type 2 diabetes mellitus	5.05e-05	0.000677	CcSEcCtD
Verapamil—Visual impairment—Ramipril—type 2 diabetes mellitus	5.03e-05	0.000674	CcSEcCtD
Verapamil—Discomfort—Metformin—type 2 diabetes mellitus	5.02e-05	0.000673	CcSEcCtD
Verapamil—Fatigue—Gliclazide—type 2 diabetes mellitus	5.02e-05	0.000673	CcSEcCtD
Verapamil—ABCB1—kidney—type 2 diabetes mellitus	5.01e-05	0.00239	CbGeAlD
Verapamil—Nausea—Glipizide—type 2 diabetes mellitus	5e-05	0.000671	CcSEcCtD
Verapamil—Vomiting—Glimepiride—type 2 diabetes mellitus	5e-05	0.00067	CcSEcCtD
Verapamil—Hypotension—Valsartan—type 2 diabetes mellitus	5e-05	0.00067	CcSEcCtD
Verapamil—Vision blurred—Losartan—type 2 diabetes mellitus	5e-05	0.00067	CcSEcCtD
Verapamil—Vomiting—Sitagliptin—type 2 diabetes mellitus	4.98e-05	0.000668	CcSEcCtD
Verapamil—Pain—Gliclazide—type 2 diabetes mellitus	4.98e-05	0.000667	CcSEcCtD
Verapamil—Constipation—Gliclazide—type 2 diabetes mellitus	4.98e-05	0.000667	CcSEcCtD
Verapamil—ABCB1—pancreas—type 2 diabetes mellitus	4.98e-05	0.00237	CbGeAlD
Verapamil—Tremor—Losartan—type 2 diabetes mellitus	4.97e-05	0.000666	CcSEcCtD
Verapamil—Rash—Glimepiride—type 2 diabetes mellitus	4.96e-05	0.000664	CcSEcCtD
Verapamil—Dermatitis—Glimepiride—type 2 diabetes mellitus	4.95e-05	0.000664	CcSEcCtD
Verapamil—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	4.95e-05	0.000664	CcSEcCtD
Verapamil—Rash—Sitagliptin—type 2 diabetes mellitus	4.94e-05	0.000662	CcSEcCtD
Verapamil—Dermatitis—Sitagliptin—type 2 diabetes mellitus	4.94e-05	0.000662	CcSEcCtD
Verapamil—Erythema multiforme—Ramipril—type 2 diabetes mellitus	4.94e-05	0.000662	CcSEcCtD
Verapamil—Headache—Glimepiride—type 2 diabetes mellitus	4.93e-05	0.00066	CcSEcCtD
Verapamil—Tofisopam—CYP3A4—type 2 diabetes mellitus	4.92e-05	1	CrCbGaD
Verapamil—Headache—Sitagliptin—type 2 diabetes mellitus	4.91e-05	0.000658	CcSEcCtD
Verapamil—ABCB1—cortex of kidney—type 2 diabetes mellitus	4.88e-05	0.00233	CbGeAlD
Verapamil—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	4.87e-05	0.000653	CcSEcCtD
Verapamil—Agitation—Losartan—type 2 diabetes mellitus	4.87e-05	0.000653	CcSEcCtD
Verapamil—Oedema—Metformin—type 2 diabetes mellitus	4.87e-05	0.000653	CcSEcCtD
Verapamil—Tinnitus—Ramipril—type 2 diabetes mellitus	4.87e-05	0.000653	CcSEcCtD
Verapamil—Hypertension—Irbesartan—type 2 diabetes mellitus	4.86e-05	0.000652	CcSEcCtD
Verapamil—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	4.85e-05	0.000651	CcSEcCtD
Verapamil—Flushing—Ramipril—type 2 diabetes mellitus	4.85e-05	0.00065	CcSEcCtD
Verapamil—Angioedema—Losartan—type 2 diabetes mellitus	4.84e-05	0.000649	CcSEcCtD
Verapamil—Infection—Metformin—type 2 diabetes mellitus	4.84e-05	0.000649	CcSEcCtD
Verapamil—Insomnia—Valsartan—type 2 diabetes mellitus	4.84e-05	0.000649	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	4.82e-05	0.000646	CcSEcCtD
Verapamil—Paraesthesia—Valsartan—type 2 diabetes mellitus	4.8e-05	0.000644	CcSEcCtD
Verapamil—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	4.8e-05	0.000643	CcSEcCtD
Verapamil—Myalgia—Irbesartan—type 2 diabetes mellitus	4.8e-05	0.000643	CcSEcCtD
Verapamil—Arthralgia—Irbesartan—type 2 diabetes mellitus	4.8e-05	0.000643	CcSEcCtD
Verapamil—Chest pain—Irbesartan—type 2 diabetes mellitus	4.8e-05	0.000643	CcSEcCtD
Verapamil—Shock—Metformin—type 2 diabetes mellitus	4.79e-05	0.000642	CcSEcCtD
Verapamil—Insomnia—Orlistat—type 2 diabetes mellitus	4.78e-05	0.000641	CcSEcCtD
Verapamil—Hypersensitivity—Glyburide—type 2 diabetes mellitus	4.78e-05	0.00064	CcSEcCtD
Verapamil—Dyspnoea—Valsartan—type 2 diabetes mellitus	4.77e-05	0.000639	CcSEcCtD
Verapamil—Vertigo—Losartan—type 2 diabetes mellitus	4.76e-05	0.000638	CcSEcCtD
Verapamil—Somnolence—Valsartan—type 2 diabetes mellitus	4.76e-05	0.000637	CcSEcCtD
Verapamil—Syncope—Losartan—type 2 diabetes mellitus	4.75e-05	0.000637	CcSEcCtD
Verapamil—Paraesthesia—Orlistat—type 2 diabetes mellitus	4.75e-05	0.000636	CcSEcCtD
Verapamil—Discomfort—Irbesartan—type 2 diabetes mellitus	4.74e-05	0.000635	CcSEcCtD
Verapamil—Hyperhidrosis—Metformin—type 2 diabetes mellitus	4.71e-05	0.000631	CcSEcCtD
Verapamil—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.71e-05	0.000631	CcSEcCtD
Verapamil—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.69e-05	0.000629	CcSEcCtD
Verapamil—Dry mouth—Irbesartan—type 2 diabetes mellitus	4.69e-05	0.000629	CcSEcCtD
Verapamil—Palpitations—Losartan—type 2 diabetes mellitus	4.68e-05	0.000628	CcSEcCtD
Verapamil—Nausea—Glimepiride—type 2 diabetes mellitus	4.67e-05	0.000626	CcSEcCtD
Verapamil—Loss of consciousness—Losartan—type 2 diabetes mellitus	4.66e-05	0.000625	CcSEcCtD
Verapamil—Nausea—Sitagliptin—type 2 diabetes mellitus	4.66e-05	0.000624	CcSEcCtD
Verapamil—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.65e-05	0.000624	CcSEcCtD
Verapamil—Asthenia—Glyburide—type 2 diabetes mellitus	4.65e-05	0.000624	CcSEcCtD
Verapamil—Urticaria—Gliclazide—type 2 diabetes mellitus	4.63e-05	0.00062	CcSEcCtD
Verapamil—Alopecia—Ramipril—type 2 diabetes mellitus	4.61e-05	0.000618	CcSEcCtD
Verapamil—Fatigue—Valsartan—type 2 diabetes mellitus	4.61e-05	0.000618	CcSEcCtD
Verapamil—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	4.6e-05	0.000616	CcSEcCtD
Verapamil—Oedema—Irbesartan—type 2 diabetes mellitus	4.6e-05	0.000616	CcSEcCtD
Verapamil—Pruritus—Glyburide—type 2 diabetes mellitus	4.59e-05	0.000615	CcSEcCtD
Verapamil—Constipation—Valsartan—type 2 diabetes mellitus	4.57e-05	0.000613	CcSEcCtD
Verapamil—Infection—Irbesartan—type 2 diabetes mellitus	4.57e-05	0.000612	CcSEcCtD
Verapamil—Fatigue—Orlistat—type 2 diabetes mellitus	4.56e-05	0.000611	CcSEcCtD
Verapamil—Hypotension—Metformin—type 2 diabetes mellitus	4.55e-05	0.00061	CcSEcCtD
Verapamil—Shock—Irbesartan—type 2 diabetes mellitus	4.52e-05	0.000606	CcSEcCtD
Verapamil—Pain—Orlistat—type 2 diabetes mellitus	4.52e-05	0.000606	CcSEcCtD
Verapamil—ABCB1—adipose tissue—type 2 diabetes mellitus	4.52e-05	0.00215	CbGeAlD
Verapamil—Myalgia—Losartan—type 2 diabetes mellitus	4.51e-05	0.000605	CcSEcCtD
Verapamil—Chest pain—Losartan—type 2 diabetes mellitus	4.51e-05	0.000605	CcSEcCtD
Verapamil—Arthralgia—Losartan—type 2 diabetes mellitus	4.51e-05	0.000605	CcSEcCtD
Verapamil—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.51e-05	0.000604	CcSEcCtD
Verapamil—Tachycardia—Irbesartan—type 2 diabetes mellitus	4.49e-05	0.000601	CcSEcCtD
Verapamil—CYP3A4—liver—type 2 diabetes mellitus	4.48e-05	0.00213	CbGeAlD
Verapamil—Rash—Bromocriptine—type 2 diabetes mellitus	4.47e-05	0.000599	CcSEcCtD
Verapamil—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.47e-05	0.000599	CcSEcCtD
Verapamil—Discomfort—Losartan—type 2 diabetes mellitus	4.46e-05	0.000598	CcSEcCtD
Verapamil—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.44e-05	0.000596	CcSEcCtD
Verapamil—Headache—Bromocriptine—type 2 diabetes mellitus	4.44e-05	0.000596	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.44e-05	0.000595	CcSEcCtD
Verapamil—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.44e-05	0.000595	CcSEcCtD
Verapamil—Dry mouth—Losartan—type 2 diabetes mellitus	4.41e-05	0.000592	CcSEcCtD
Verapamil—CYP2D6—liver—type 2 diabetes mellitus	4.4e-05	0.0021	CbGeAlD
Verapamil—Paraesthesia—Metformin—type 2 diabetes mellitus	4.37e-05	0.000586	CcSEcCtD
Verapamil—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.37e-05	0.000586	CcSEcCtD
Verapamil—Confusional state—Losartan—type 2 diabetes mellitus	4.36e-05	0.000585	CcSEcCtD
Verapamil—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.36e-05	0.000584	CcSEcCtD
Verapamil—Dyspnoea—Metformin—type 2 diabetes mellitus	4.34e-05	0.000582	CcSEcCtD
Verapamil—Somnolence—Metformin—type 2 diabetes mellitus	4.33e-05	0.00058	CcSEcCtD
Verapamil—Anaphylactic shock—Losartan—type 2 diabetes mellitus	4.33e-05	0.00058	CcSEcCtD
Verapamil—Oedema—Losartan—type 2 diabetes mellitus	4.33e-05	0.00058	CcSEcCtD
Verapamil—Infection—Losartan—type 2 diabetes mellitus	4.3e-05	0.000576	CcSEcCtD
Verapamil—Hypotension—Irbesartan—type 2 diabetes mellitus	4.3e-05	0.000576	CcSEcCtD
Verapamil—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.29e-05	0.000575	CcSEcCtD
Verapamil—Dyspepsia—Metformin—type 2 diabetes mellitus	4.29e-05	0.000575	CcSEcCtD
Verapamil—Tremor—Ramipril—type 2 diabetes mellitus	4.26e-05	0.000571	CcSEcCtD
Verapamil—Shock—Losartan—type 2 diabetes mellitus	4.26e-05	0.000571	CcSEcCtD
Verapamil—Urticaria—Valsartan—type 2 diabetes mellitus	4.25e-05	0.00057	CcSEcCtD
Verapamil—Tachycardia—Losartan—type 2 diabetes mellitus	4.22e-05	0.000566	CcSEcCtD
Verapamil—Nausea—Bromocriptine—type 2 diabetes mellitus	4.21e-05	0.000565	CcSEcCtD
Verapamil—Fatigue—Metformin—type 2 diabetes mellitus	4.2e-05	0.000563	CcSEcCtD
Verapamil—Urticaria—Orlistat—type 2 diabetes mellitus	4.2e-05	0.000563	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.19e-05	0.000561	CcSEcCtD
Verapamil—Hyperhidrosis—Losartan—type 2 diabetes mellitus	4.18e-05	0.000561	CcSEcCtD
Verapamil—Asthenia—Gliclazide—type 2 diabetes mellitus	4.18e-05	0.00056	CcSEcCtD
Verapamil—Agitation—Ramipril—type 2 diabetes mellitus	4.18e-05	0.00056	CcSEcCtD
Verapamil—Constipation—Metformin—type 2 diabetes mellitus	4.17e-05	0.000558	CcSEcCtD
Verapamil—Angioedema—Ramipril—type 2 diabetes mellitus	4.15e-05	0.000557	CcSEcCtD
Verapamil—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.13e-05	0.000553	CcSEcCtD
Verapamil—Vomiting—Glyburide—type 2 diabetes mellitus	4.12e-05	0.000553	CcSEcCtD
Verapamil—Pruritus—Gliclazide—type 2 diabetes mellitus	4.12e-05	0.000552	CcSEcCtD
Verapamil—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.1e-05	0.000549	CcSEcCtD
Verapamil—Rash—Glyburide—type 2 diabetes mellitus	4.09e-05	0.000548	CcSEcCtD
Verapamil—Somnolence—Irbesartan—type 2 diabetes mellitus	4.09e-05	0.000548	CcSEcCtD
Verapamil—Dermatitis—Glyburide—type 2 diabetes mellitus	4.08e-05	0.000547	CcSEcCtD
Verapamil—Vertigo—Ramipril—type 2 diabetes mellitus	4.08e-05	0.000547	CcSEcCtD
Verapamil—Syncope—Ramipril—type 2 diabetes mellitus	4.08e-05	0.000546	CcSEcCtD
Verapamil—Headache—Glyburide—type 2 diabetes mellitus	4.06e-05	0.000544	CcSEcCtD
Verapamil—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.05e-05	0.000542	CcSEcCtD
Verapamil—Hypotension—Losartan—type 2 diabetes mellitus	4.04e-05	0.000542	CcSEcCtD
Verapamil—Palpitations—Ramipril—type 2 diabetes mellitus	4.02e-05	0.000538	CcSEcCtD
Verapamil—Feeling abnormal—Metformin—type 2 diabetes mellitus	4.01e-05	0.000538	CcSEcCtD
Verapamil—Loss of consciousness—Ramipril—type 2 diabetes mellitus	4e-05	0.000535	CcSEcCtD
Verapamil—Diarrhoea—Gliclazide—type 2 diabetes mellitus	3.98e-05	0.000534	CcSEcCtD
Verapamil—Fatigue—Irbesartan—type 2 diabetes mellitus	3.96e-05	0.000531	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	3.94e-05	0.000528	CcSEcCtD
Verapamil—Hypersensitivity—Valsartan—type 2 diabetes mellitus	3.94e-05	0.000528	CcSEcCtD
Verapamil—Convulsion—Ramipril—type 2 diabetes mellitus	3.94e-05	0.000528	CcSEcCtD
Verapamil—Constipation—Irbesartan—type 2 diabetes mellitus	3.93e-05	0.000527	CcSEcCtD
Verapamil—Pain—Irbesartan—type 2 diabetes mellitus	3.93e-05	0.000527	CcSEcCtD
Verapamil—Insomnia—Losartan—type 2 diabetes mellitus	3.91e-05	0.000524	CcSEcCtD
Verapamil—Hypersensitivity—Orlistat—type 2 diabetes mellitus	3.89e-05	0.000522	CcSEcCtD
Verapamil—Paraesthesia—Losartan—type 2 diabetes mellitus	3.89e-05	0.000521	CcSEcCtD
Verapamil—Urticaria—Metformin—type 2 diabetes mellitus	3.87e-05	0.000519	CcSEcCtD
Verapamil—Chest pain—Ramipril—type 2 diabetes mellitus	3.87e-05	0.000519	CcSEcCtD
Verapamil—Arthralgia—Ramipril—type 2 diabetes mellitus	3.87e-05	0.000519	CcSEcCtD
Verapamil—Myalgia—Ramipril—type 2 diabetes mellitus	3.87e-05	0.000519	CcSEcCtD
Verapamil—Dyspnoea—Losartan—type 2 diabetes mellitus	3.86e-05	0.000517	CcSEcCtD
Verapamil—Nausea—Glyburide—type 2 diabetes mellitus	3.85e-05	0.000516	CcSEcCtD
Verapamil—Dizziness—Gliclazide—type 2 diabetes mellitus	3.85e-05	0.000516	CcSEcCtD
Verapamil—Somnolence—Losartan—type 2 diabetes mellitus	3.85e-05	0.000516	CcSEcCtD
Verapamil—Asthenia—Valsartan—type 2 diabetes mellitus	3.84e-05	0.000514	CcSEcCtD
Verapamil—Discomfort—Ramipril—type 2 diabetes mellitus	3.82e-05	0.000512	CcSEcCtD
Verapamil—Dyspepsia—Losartan—type 2 diabetes mellitus	3.81e-05	0.00051	CcSEcCtD
Verapamil—Asthenia—Orlistat—type 2 diabetes mellitus	3.79e-05	0.000508	CcSEcCtD
Verapamil—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.79e-05	0.000508	CcSEcCtD
Verapamil—Pruritus—Valsartan—type 2 diabetes mellitus	3.78e-05	0.000507	CcSEcCtD
Verapamil—Dry mouth—Ramipril—type 2 diabetes mellitus	3.78e-05	0.000507	CcSEcCtD
Verapamil—Confusional state—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000501	CcSEcCtD
Verapamil—Pruritus—Orlistat—type 2 diabetes mellitus	3.74e-05	0.000501	CcSEcCtD
Verapamil—Fatigue—Losartan—type 2 diabetes mellitus	3.73e-05	0.0005	CcSEcCtD
Verapamil—Oedema—Ramipril—type 2 diabetes mellitus	3.71e-05	0.000497	CcSEcCtD
Verapamil—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	3.71e-05	0.000497	CcSEcCtD
Verapamil—Vomiting—Gliclazide—type 2 diabetes mellitus	3.7e-05	0.000496	CcSEcCtD
Verapamil—Pain—Losartan—type 2 diabetes mellitus	3.7e-05	0.000496	CcSEcCtD
Verapamil—Constipation—Losartan—type 2 diabetes mellitus	3.7e-05	0.000496	CcSEcCtD
Verapamil—Rash—Gliclazide—type 2 diabetes mellitus	3.67e-05	0.000492	CcSEcCtD
Verapamil—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.67e-05	0.000492	CcSEcCtD
Verapamil—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.66e-05	0.000491	CcSEcCtD
Verapamil—Urticaria—Irbesartan—type 2 diabetes mellitus	3.65e-05	0.00049	CcSEcCtD
Verapamil—Shock—Ramipril—type 2 diabetes mellitus	3.65e-05	0.000489	CcSEcCtD
Verapamil—Headache—Gliclazide—type 2 diabetes mellitus	3.65e-05	0.000489	CcSEcCtD
Verapamil—Tachycardia—Ramipril—type 2 diabetes mellitus	3.62e-05	0.000485	CcSEcCtD
Verapamil—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.62e-05	0.000485	CcSEcCtD
Verapamil—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.59e-05	0.000481	CcSEcCtD
Verapamil—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.57e-05	0.000478	CcSEcCtD
Verapamil—Dizziness—Valsartan—type 2 diabetes mellitus	3.54e-05	0.000474	CcSEcCtD
Verapamil—Dizziness—Orlistat—type 2 diabetes mellitus	3.5e-05	0.000469	CcSEcCtD
Verapamil—Asthenia—Metformin—type 2 diabetes mellitus	3.5e-05	0.000468	CcSEcCtD
Verapamil—Hypotension—Ramipril—type 2 diabetes mellitus	3.47e-05	0.000465	CcSEcCtD
Verapamil—Nausea—Gliclazide—type 2 diabetes mellitus	3.46e-05	0.000464	CcSEcCtD
Verapamil—Pruritus—Metformin—type 2 diabetes mellitus	3.45e-05	0.000462	CcSEcCtD
Verapamil—Urticaria—Losartan—type 2 diabetes mellitus	3.44e-05	0.000461	CcSEcCtD
Verapamil—Vomiting—Valsartan—type 2 diabetes mellitus	3.4e-05	0.000456	CcSEcCtD
Verapamil—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.39e-05	0.000454	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.38e-05	0.000453	CcSEcCtD
Verapamil—Rash—Valsartan—type 2 diabetes mellitus	3.37e-05	0.000452	CcSEcCtD
Verapamil—Dermatitis—Valsartan—type 2 diabetes mellitus	3.37e-05	0.000452	CcSEcCtD
Verapamil—Vomiting—Orlistat—type 2 diabetes mellitus	3.36e-05	0.00045	CcSEcCtD
Verapamil—Insomnia—Ramipril—type 2 diabetes mellitus	3.36e-05	0.00045	CcSEcCtD
Verapamil—Headache—Valsartan—type 2 diabetes mellitus	3.35e-05	0.000449	CcSEcCtD
Verapamil—Diarrhoea—Metformin—type 2 diabetes mellitus	3.33e-05	0.000447	CcSEcCtD
Verapamil—Rash—Orlistat—type 2 diabetes mellitus	3.33e-05	0.000447	CcSEcCtD
Verapamil—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.33e-05	0.000446	CcSEcCtD
Verapamil—Dermatitis—Orlistat—type 2 diabetes mellitus	3.33e-05	0.000446	CcSEcCtD
Verapamil—Headache—Orlistat—type 2 diabetes mellitus	3.31e-05	0.000444	CcSEcCtD
Verapamil—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.31e-05	0.000443	CcSEcCtD
Verapamil—Asthenia—Irbesartan—type 2 diabetes mellitus	3.3e-05	0.000442	CcSEcCtD
Verapamil—Somnolence—Ramipril—type 2 diabetes mellitus	3.3e-05	0.000442	CcSEcCtD
Verapamil—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.27e-05	0.000438	CcSEcCtD
Verapamil—Pruritus—Irbesartan—type 2 diabetes mellitus	3.25e-05	0.000436	CcSEcCtD
Verapamil—Dizziness—Metformin—type 2 diabetes mellitus	3.22e-05	0.000432	CcSEcCtD
Verapamil—Fatigue—Ramipril—type 2 diabetes mellitus	3.2e-05	0.000429	CcSEcCtD
Verapamil—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.19e-05	0.000427	CcSEcCtD
Verapamil—Nausea—Valsartan—type 2 diabetes mellitus	3.18e-05	0.000426	CcSEcCtD
Verapamil—Constipation—Ramipril—type 2 diabetes mellitus	3.17e-05	0.000425	CcSEcCtD
Verapamil—ABCB1—liver—type 2 diabetes mellitus	3.17e-05	0.00151	CbGeAlD
Verapamil—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.15e-05	0.000422	CcSEcCtD
Verapamil—Nausea—Orlistat—type 2 diabetes mellitus	3.14e-05	0.000421	CcSEcCtD
Verapamil—Asthenia—Losartan—type 2 diabetes mellitus	3.1e-05	0.000416	CcSEcCtD
Verapamil—Vomiting—Metformin—type 2 diabetes mellitus	3.1e-05	0.000415	CcSEcCtD
Verapamil—Rash—Metformin—type 2 diabetes mellitus	3.07e-05	0.000412	CcSEcCtD
Verapamil—Dermatitis—Metformin—type 2 diabetes mellitus	3.07e-05	0.000411	CcSEcCtD
Verapamil—Pruritus—Losartan—type 2 diabetes mellitus	3.06e-05	0.00041	CcSEcCtD
Verapamil—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.06e-05	0.00041	CcSEcCtD
Verapamil—Headache—Metformin—type 2 diabetes mellitus	3.05e-05	0.000409	CcSEcCtD
Verapamil—Dizziness—Irbesartan—type 2 diabetes mellitus	3.04e-05	0.000407	CcSEcCtD
Verapamil—Diarrhoea—Losartan—type 2 diabetes mellitus	2.96e-05	0.000397	CcSEcCtD
Verapamil—Urticaria—Ramipril—type 2 diabetes mellitus	2.95e-05	0.000395	CcSEcCtD
Verapamil—Vomiting—Irbesartan—type 2 diabetes mellitus	2.92e-05	0.000392	CcSEcCtD
Verapamil—Rash—Irbesartan—type 2 diabetes mellitus	2.9e-05	0.000389	CcSEcCtD
Verapamil—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.9e-05	0.000388	CcSEcCtD
Verapamil—Nausea—Metformin—type 2 diabetes mellitus	2.89e-05	0.000388	CcSEcCtD
Verapamil—Headache—Irbesartan—type 2 diabetes mellitus	2.88e-05	0.000386	CcSEcCtD
Verapamil—Dizziness—Losartan—type 2 diabetes mellitus	2.86e-05	0.000383	CcSEcCtD
Verapamil—Vomiting—Losartan—type 2 diabetes mellitus	2.75e-05	0.000369	CcSEcCtD
Verapamil—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.73e-05	0.000366	CcSEcCtD
Verapamil—Nausea—Irbesartan—type 2 diabetes mellitus	2.73e-05	0.000366	CcSEcCtD
Verapamil—Rash—Losartan—type 2 diabetes mellitus	2.73e-05	0.000366	CcSEcCtD
Verapamil—Dermatitis—Losartan—type 2 diabetes mellitus	2.73e-05	0.000365	CcSEcCtD
Verapamil—Headache—Losartan—type 2 diabetes mellitus	2.71e-05	0.000363	CcSEcCtD
Verapamil—Asthenia—Ramipril—type 2 diabetes mellitus	2.66e-05	0.000357	CcSEcCtD
Verapamil—Pruritus—Ramipril—type 2 diabetes mellitus	2.62e-05	0.000352	CcSEcCtD
Verapamil—Nausea—Losartan—type 2 diabetes mellitus	2.57e-05	0.000344	CcSEcCtD
Verapamil—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.54e-05	0.00034	CcSEcCtD
Verapamil—Dizziness—Ramipril—type 2 diabetes mellitus	2.45e-05	0.000329	CcSEcCtD
Verapamil—Vomiting—Ramipril—type 2 diabetes mellitus	2.36e-05	0.000316	CcSEcCtD
Verapamil—Rash—Ramipril—type 2 diabetes mellitus	2.34e-05	0.000314	CcSEcCtD
Verapamil—Dermatitis—Ramipril—type 2 diabetes mellitus	2.34e-05	0.000313	CcSEcCtD
Verapamil—Headache—Ramipril—type 2 diabetes mellitus	2.32e-05	0.000312	CcSEcCtD
Verapamil—Nausea—Ramipril—type 2 diabetes mellitus	2.2e-05	0.000295	CcSEcCtD
Verapamil—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	7.35e-07	1.17e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	7.35e-07	1.17e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	7.35e-07	1.17e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	7.34e-07	1.16e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	7.33e-07	1.16e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—SRC—type 2 diabetes mellitus	7.31e-07	1.16e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	7.28e-07	1.15e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	7.28e-07	1.15e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	7.27e-07	1.15e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	7.22e-07	1.14e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	7.22e-07	1.14e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	7.22e-07	1.14e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	7.19e-07	1.14e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	7.19e-07	1.14e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	7.15e-07	1.13e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	7.15e-07	1.13e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	7.12e-07	1.13e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	7.11e-07	1.13e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	7.1e-07	1.12e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.06e-07	1.12e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	7.05e-07	1.12e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.05e-07	1.12e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	7.04e-07	1.12e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	7.04e-07	1.12e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	7.02e-07	1.11e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	7.02e-07	1.11e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	7.02e-07	1.11e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	7e-07	1.11e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	6.99e-07	1.11e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	6.96e-07	1.1e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	6.93e-07	1.1e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.88e-07	1.09e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	6.88e-07	1.09e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	6.88e-07	1.09e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	6.85e-07	1.09e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	6.84e-07	1.08e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	6.76e-07	1.07e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	6.75e-07	1.07e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	6.73e-07	1.07e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	6.73e-07	1.07e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	6.72e-07	1.06e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	6.72e-07	1.06e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	6.66e-07	1.05e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	6.65e-07	1.05e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	6.63e-07	1.05e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	6.6e-07	1.05e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	6.56e-07	1.04e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	6.54e-07	1.04e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—TGFB1—type 2 diabetes mellitus	6.53e-07	1.03e-05	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—AKT1—type 2 diabetes mellitus	6.51e-07	1.03e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	6.49e-07	1.03e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	6.49e-07	1.03e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	6.49e-07	1.03e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.49e-07	1.03e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	6.49e-07	1.03e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	6.48e-07	1.03e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	6.46e-07	1.02e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.45e-07	1.02e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	6.43e-07	1.02e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.43e-07	1.02e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	6.42e-07	1.02e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—EGFR—type 2 diabetes mellitus	6.41e-07	1.01e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	6.4e-07	1.01e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	6.39e-07	1.01e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	6.38e-07	1.01e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	6.38e-07	1.01e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	6.37e-07	1.01e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	6.37e-07	1.01e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	6.36e-07	1.01e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	6.33e-07	1e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	6.33e-07	1e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	6.33e-07	1e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	6.32e-07	1e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	6.29e-07	9.96e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	6.29e-07	9.96e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	6.27e-07	9.93e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	6.27e-07	9.93e-06	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—AKT1—type 2 diabetes mellitus	6.21e-07	9.84e-06	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	6.2e-07	9.83e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	6.19e-07	9.8e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	6.18e-07	9.79e-06	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—AKT1—type 2 diabetes mellitus	6.17e-07	9.77e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	6.16e-07	9.75e-06	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	6.14e-07	9.73e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	6.14e-07	9.72e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	6.13e-07	9.72e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	6.12e-07	9.69e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	6.11e-07	9.67e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	6.1e-07	9.67e-06	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	6.09e-07	9.64e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	6.06e-07	9.61e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	6.05e-07	9.59e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	6.03e-07	9.55e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	6.03e-07	9.55e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	6.02e-07	9.53e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	5.97e-07	9.45e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	5.96e-07	9.45e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	5.96e-07	9.44e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	5.95e-07	9.42e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	5.91e-07	9.36e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	5.88e-07	9.32e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	5.86e-07	9.28e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	5.78e-07	9.16e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	5.78e-07	9.16e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	5.76e-07	9.13e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	5.73e-07	9.08e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	5.71e-07	9.05e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	5.68e-07	8.99e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	5.68e-07	8.99e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	5.68e-07	8.99e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	5.67e-07	8.99e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	5.64e-07	8.94e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	5.61e-07	8.89e-06	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	5.58e-07	8.84e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.57e-07	8.83e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	5.56e-07	8.81e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	5.54e-07	8.78e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	5.54e-07	8.77e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5.52e-07	8.75e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.5e-07	8.71e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	5.5e-07	8.71e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	5.49e-07	8.7e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	5.49e-07	8.7e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	5.47e-07	8.67e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	5.45e-07	8.64e-06	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—AKT1—type 2 diabetes mellitus	5.42e-07	8.58e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	5.4e-07	8.56e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	5.4e-07	8.56e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	5.4e-07	8.55e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	5.38e-07	8.53e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	5.36e-07	8.5e-06	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	5.34e-07	8.46e-06	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	5.34e-07	8.46e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	5.32e-07	8.43e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	5.32e-07	8.43e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	5.27e-07	8.35e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	5.27e-07	8.35e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	5.25e-07	8.32e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	5.25e-07	8.32e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	5.24e-07	8.3e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	5.22e-07	8.27e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	5.22e-07	8.26e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	5.22e-07	8.26e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	5.19e-07	8.23e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	5.19e-07	8.22e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	5.17e-07	8.19e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	5.15e-07	8.16e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	5.13e-07	8.13e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	5.13e-07	8.13e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	5.1e-07	8.08e-06	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—AKT1—type 2 diabetes mellitus	5.06e-07	8.02e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	5.05e-07	8.01e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	5.01e-07	7.94e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	5e-07	7.93e-06	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—AKT1—type 2 diabetes mellitus	4.99e-07	7.91e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	4.97e-07	7.87e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	4.95e-07	7.84e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	4.93e-07	7.8e-06	CbGpPWpGaD
Verapamil—ABCC1—Disease—IL6—type 2 diabetes mellitus	4.92e-07	7.8e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.92e-07	7.8e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.92e-07	7.8e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	4.91e-07	7.78e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	4.9e-07	7.76e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	4.89e-07	7.75e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	4.88e-07	7.73e-06	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	4.88e-07	7.73e-06	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—AKT1—type 2 diabetes mellitus	4.85e-07	7.69e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	4.85e-07	7.69e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	4.77e-07	7.56e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	4.75e-07	7.53e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	4.72e-07	7.48e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	4.69e-07	7.44e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	4.69e-07	7.43e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	4.6e-07	7.29e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	4.58e-07	7.25e-06	CbGpPWpGaD
Verapamil—ABCC1—Disease—AKT1—type 2 diabetes mellitus	4.54e-07	7.2e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	4.52e-07	7.16e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	4.52e-07	7.16e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	4.51e-07	7.14e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—INS—type 2 diabetes mellitus	4.49e-07	7.11e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	4.42e-07	7e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	4.31e-07	6.83e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	4.28e-07	6.78e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	4.28e-07	6.77e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.24e-07	6.72e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.24e-07	6.72e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	4.23e-07	6.7e-06	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—AKT1—type 2 diabetes mellitus	4.23e-07	6.7e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.22e-07	6.69e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	4.22e-07	6.68e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	4.21e-07	6.67e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	4.19e-07	6.65e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	4.19e-07	6.64e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	4.17e-07	6.6e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	4.15e-07	6.57e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	4.13e-07	6.55e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	4.12e-07	6.52e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.04e-07	6.41e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	4.03e-07	6.39e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	4.03e-07	6.39e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	3.94e-07	6.24e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.94e-07	6.24e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.93e-07	6.23e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	3.88e-07	6.14e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.86e-07	6.12e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	3.84e-07	6.09e-06	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—AKT1—type 2 diabetes mellitus	3.8e-07	6.03e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.78e-07	5.99e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.77e-07	5.97e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.71e-07	5.88e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	3.71e-07	5.88e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	3.69e-07	5.84e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	3.68e-07	5.83e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	3.68e-07	5.83e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.67e-07	5.81e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	3.65e-07	5.79e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.62e-07	5.74e-06	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	3.61e-07	5.73e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	3.6e-07	5.7e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	3.58e-07	5.68e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.48e-07	5.51e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.41e-07	5.4e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	3.39e-07	5.37e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	3.36e-07	5.33e-06	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	3.35e-07	5.3e-06	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	3.32e-07	5.26e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.3e-07	5.23e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	3.29e-07	5.2e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.25e-07	5.15e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.24e-07	5.13e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.2e-07	5.07e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.14e-07	4.98e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	3.14e-07	4.98e-06	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	3.09e-07	4.89e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.87e-07	4.55e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.82e-07	4.47e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.77e-07	4.38e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.54e-07	4.02e-06	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	2.45e-07	3.89e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.43e-07	3.84e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.43e-07	3.84e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	2.4e-07	3.8e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.22e-07	3.51e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	2.08e-07	3.29e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.85e-07	2.94e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.81e-07	2.87e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.71e-07	2.7e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.69e-07	2.68e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.44e-07	2.29e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.11e-07	1.77e-06	CbGpPWpGaD
